NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
UDP N-acetylglucosamine2-epimerase/N-acetylmannosamine-kinase (GNE) gene mutations can cause mostly autosomal-recessive myopathy with juvenile-onset known as hereditary inclusion-body myopathy (HIBM).
|
30990900 |
2019 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
In addition, the literature on DMRV was reviewed to provide an overview of the disease and broaden the mutational spectrum of the GNE gene in China.
|
30112071 |
2018 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Individuals with mutations in presenilin or amyloid precursor protein (APP) gene develop AD while mutations in GNE (UDP <i>N</i>-acetylglucosamine 2 epimerase/<i>N</i>-acetyl Mannosamine kinase), key sialic acid biosynthesis enzyme, cause GNEM.
|
30374284 |
2018 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
This finding broadens the GNE gene mutation spectrum and extends the GNE myopathy phenotype spectrum.
|
30160005 |
2018 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Missing genetic variations in GNE myopathy: rearrangement hotspots encompassing 5'UTR and founder allele.
|
27829678 |
2017 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Further, GNE carrying the M743T mutation, the most frequent mutation in GNE myopathy, has a 10-fold lower binding affinity to α-actinin 2 than intact GNE.
|
27023225 |
2017 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Identification of an Alu element-mediated deletion in the promoter region of GNE in siblings with GNE myopathy.
|
28717665 |
2017 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
These results show that serum and muscle free SA is severely reduced in GNEM, which is consistent with the biochemical defect in SA synthesis associated with GNE mutations.
|
28267778 |
2017 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
We report a patient with GNE myopathy with a homozygous mutation (c.1505-4G>A) in GNE gene.
|
27919547 |
2017 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Safety, pharmacokinetics and sialic acid production after oral administration of N-acetylmannosamine (ManNAc) to subjects with GNE myopathy.
|
28641925 |
2017 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
GNE myopathy is a rare autosomal recessive inheritance disease due to the mutation of GNE gene.
|
28284578 |
2017 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Muscle biopsy with dystrophic pattern and rimmed vacuoles: GNE myopathy in a Brazilian patient.
|
28099567 |
2017 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Genetic defects of the GNE gene which encodes a critical bifunctional enzyme for sialic acid biosynthesis, lead to GNE myopathy, a disease manifesting with progressive muscle atrophy and weakness.
|
28505249 |
2017 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Genetics of GNE myopathy in the non-Jewish Persian population.
|
25966635 |
2016 |
NONAKA MYOPATHY
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Genetic defects in the hexosamine and sialic acid biosynthesis pathway.
|
26721333 |
2016 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutation of methionine 743 in the GNE leads to a 30% reduction of the enzyme activity and is responsible for an aggressive form of GNE myopathy.
|
27037841 |
2016 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
This study confirms that c.2228T>C (p.M743T) is the most prevalent disease-causing variant in the non-Jewish Persian population, but other GNE variants can cause GNE myopathy in this population.
|
25966635 |
2016 |
NONAKA MYOPATHY
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
NONAKA MYOPATHY
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Mutational spectrum and clinical features in 35 unrelated mainland Chinese patients with GNE myopathy.
|
25986339 |
2015 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
GNE myopathy: current update and future therapy.
|
25002140 |
2015 |
NONAKA MYOPATHY
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Novel Mutation of the GNE Gene Presenting Atypical Mild Clinical Feature: A Korean Case Report.
|
26161358 |
2015 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Activation of the Unfolded Protein Response in Sporadic Inclusion-Body Myositis but Not in Hereditary GNE Inclusion-Body Myopathy.
|
25978849 |
2015 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Novel Pathogenic Variants in a French Cohort Widen the Mutational Spectrum of GNE Myopathy.
|
27858732 |
2015 |
NONAKA MYOPATHY
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
GNE myopathy in Roma patients homozygous for the p.I618T founder mutation.
|
26231298 |
2015 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Novel GNE mutations found in this study expanded the mutational spectrum associated with GNE myopathy.
|
25986339 |
2015 |